IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
12 hedge funds and large institutions have $849K invested in Interpace Biosciences, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
-6
Holders Change %
-33.33%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
2
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$36.4K |
2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6K |
Top Sellers
1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$880K |
2 |
PM
Penbrook Management
New York
|
-$261K |
3 |
MFG
Magnus Financial Group
New York
|
-$150K |
4 |
Citadel Advisors
Miami,
Florida
|
-$37K |
5 |
Squarepoint
New York
|
-$13.8K |